526 related articles for article (PubMed ID: 15523350)
1. Tacrolimus ointment is effective for facial and intertriginous psoriasis.
Lebwohl M; Freeman AK; Chapman MS; Feldman SR; Hartle JE; Henning A;
J Am Acad Dermatol; 2004 Nov; 51(5):723-30. PubMed ID: 15523350
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus ointment is effective for psoriasis on the face and intertriginous areas in pediatric patients.
Brune A; Miller DW; Lin P; Cotrim-Russi D; Paller AS
Pediatr Dermatol; 2007; 24(1):76-80. PubMed ID: 17300658
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g(-1) ointment and tacrolimus 0.3 mg g(-1) ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial.
Liao YH; Chiu HC; Tseng YS; Tsai TF
Br J Dermatol; 2007 Nov; 157(5):1005-12. PubMed ID: 17935517
[TBL] [Abstract][Full Text] [Related]
4. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study.
Gribetz C; Ling M; Lebwohl M; Pariser D; Draelos Z; Gottlieb AB; Zaias N; Chen DM; Parneix-Spake A; Hultsch T; Menter A
J Am Acad Dermatol; 2004 Nov; 51(5):731-8. PubMed ID: 15523351
[TBL] [Abstract][Full Text] [Related]
5. Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas.
Lebwohl MG; Tan MH; Meador SL; Singer G
J Am Acad Dermatol; 2001 Jan; 44(1):77-82. PubMed ID: 11148481
[TBL] [Abstract][Full Text] [Related]
6. Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment.
Carroll CL; Clarke J; Camacho F; Balkrishnan R; Feldman SR
Arch Dermatol; 2005 Jan; 141(1):43-6. PubMed ID: 15655140
[TBL] [Abstract][Full Text] [Related]
7. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
8. Topical tacrolimus for the treatment of psoriasis on the face, genitalia, intertriginous areas and corporal plaques.
Martín Ezquerra G; Sánchez Regaña M; Herrera Acosta E; Umbert Millet P
J Drugs Dermatol; 2006 Apr; 5(4):334-6. PubMed ID: 16673800
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus ointment for the treatment of severe facial plaque psoriasis.
Kroft EB; Erceg A; Maimets K; Vissers W; van der Valk PG; van de Kerkhof PC
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):249-51. PubMed ID: 15752305
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of genital and facial psoriasis with tacrolimus ointment 0.1%.
Rallis E; Nasiopoulou A; Kouskoukis C; Roussaki-Schulze A; Koumantaki E; Karpouzis A; Arvanitis A
Drugs Exp Clin Res; 2005; 31(4):141-5. PubMed ID: 16223203
[TBL] [Abstract][Full Text] [Related]
11. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
[TBL] [Abstract][Full Text] [Related]
12. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
[TBL] [Abstract][Full Text] [Related]
13. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
[TBL] [Abstract][Full Text] [Related]
14. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
[TBL] [Abstract][Full Text] [Related]
15. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
[TBL] [Abstract][Full Text] [Related]
17. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus ointment 0.1% in pityriasis alba: an open-label, randomized, placebo-controlled study.
Rigopoulos D; Gregoriou S; Charissi C; Kontochristopoulos G; Kalogeromitros D; Georgala S
Br J Dermatol; 2006 Jul; 155(1):152-5. PubMed ID: 16792767
[TBL] [Abstract][Full Text] [Related]
19. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
Zhu X; Wang B; Zhao G; Gu J; Chen Z; Briantais P; Andres P
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
[TBL] [Abstract][Full Text] [Related]
20. Preliminary study of the efficacy and tolerability of combination therapy with calcipotriene ointment 0.005% and tacrolimus ointment 0.1% in the treatment of stable plaque psoriasis.
Tirado-Sánchez A; Ponce-Olivera RM
Cutis; 2012 Sep; 90(3):140-4. PubMed ID: 23094314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
